Search

Displaying all 3 results
DrugBest match

Dulaglutide

go.drugbank.com/drugs/DB09045
ApprovedInvestigational

Dulaglutide, marketed by Eli Lilly as Trulicity, is a once-weekly subcutaneous glucagon-like peptide-1 (GLP-1) receptor agonist designed using recombinant DNA technology; it has been approved as an adjunct therapy to diet and exercise in the management of 2 diabetes (T2DM). Dulaglutide was initially approved by the ...

  1. Indication

    Major Adverse Cardiovascular Events

    go.drugbank.com/conditions/DBCOND0069054
    Drugs: Dulaglutide · Liraglutide · Rivaroxaban · Rosuvastatin · Semaglutide · Tirzepatide
  2. Indication

    Type 2 Diabetes

    go.drugbank.com/conditions/DBCOND0030616
    Drugs: Acarbose · Albiglutide · Alogliptin · Bexagliflozin · Bromocriptine · Canagliflozin +40 more